Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Oxygen metabolism and barrier regulation in the intestinal mucosa
Louise E. Glover, … , J. Scott Lee, Sean P. Colgan
Louise E. Glover, … , J. Scott Lee, Sean P. Colgan
Published August 8, 2016
Citation Information: J Clin Invest. 2016;126(10):3680-3688. https://doi.org/10.1172/JCI84429.
View: Text | PDF
Review Series

Oxygen metabolism and barrier regulation in the intestinal mucosa

  • Text
  • PDF
Abstract

Mucosal surfaces are lined by epithelial cells and provide an important barrier to the flux of antigens from the outside. This barrier is provided at a number of levels, including epithelial junctional complexes, mucus production, and mucosa-derived antimicrobials. Tissue metabolism is central to the maintenance of homeostasis in the mucosa. In the intestine, for example, baseline pO2 levels are uniquely low due to counter-current blood flow and the presence of large numbers of bacteria. As such, hypoxia and HIF signaling predominates normal intestinal metabolism and barrier regulation during both homeostasis and active inflammation. Contributing factors that elicit important adaptive responses within the mucosa include the transcriptional regulation of tight junction proteins, metabolic regulation of barrier components, and changes in autophagic flux. Here, we review recent literature around the topic of hypoxia and barrier function in health and during disease.

Authors

Louise E. Glover, J. Scott Lee, Sean P. Colgan

×

Figure 2

Epithelial autophagy and barrier function.

Options: View larger image (or click on image) Download as PowerPoint
Epithelial autophagy and barrier function.
IBD results from dysregulated...
IBD results from dysregulated microbial, epithelial, and immune cell interactions. Autophagy is a key host defense mechanism for epithelial barrier protection against invasive bacteria and metabolic stressors during mucosal inflammation. IBD-associated mutations in autophagy genes have been linked to dysregulated IEC mitophagy, xenophagy, goblet cell mucus secretion, and paneth cell ER stress responses. Although the role of HIF in IEC-intrinsic autophagy in vivo has not yet been characterized, HIF has been identified as a transcriptional regulator of mitochondrial autophagy and xenophagy of IBD-associated AIEC under hypoxic conditions in vitro.
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts